Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Minden Gross LLP
On November 21, 2017, the Canadian Government released a consultation paper that contains regulatory proposals for the implementation of legal recreational cannabis.
Howie, Sacks & Henry
Preventable medical errors kill about 30,000 Canadians every year. To put those eye-popping numbers into perspective, the former president and CEO of Toronto's University Health Network...
Miller Thomson LLP
The stated intention of this legislation is to strengthen transparency and increase patient trust in the health care system.
Aird & Berlis LLP
On January 12, 2018, the Canadian Securities Administrators announced that they were considering their disclosure-based regulatory approach for issuers with U.S. marijuana-related activities.
Bennett Jones LLP
As the July 2018 date of legalization approaches, Canadian provinces continue to announce their plans for the regulation, distribution and sale of recreational cannabis.
Miller Thomson LLP
Bill S-214 ("Bill") proposes a prohibition on testing cosmetics on animals and selling cosmetics manufactured using cosmetic animal testing.
Smart & Biggar/Fetherstonhaugh
Apotex was unsuccessful in three Health Canada court challenges.
Miller Thomson LLP
The LAT CAT is now out of the bag with the recent release of one of the Licence Appeal Tribunal's most comprehensive CAT decisions in A.R. v. Allstate (Tribunal File No. 16-003415, January 5, 2018).
Smart & Biggar/Fetherstonhaugh
Separately, in Ontario, on December 12, Bill 160, the Strengthening Quality and Accountability for Patients Act, 2017, received Royal Assent.
Smart & Biggar/Fetherstonhaugh
We reported on the six Federal Court and three FCA PMNOC Regulations decisions publicly released in 2017.
Torkin Manes LLP
In November 2017, Torkin Manes published an article that provided an overview of Health Canada's consultation paper, Proposed Approach to the Regulation of Cannabis, which sets out proposals regarding the regulation...
Smart & Biggar/Fetherstonhaugh
We provided an update on biosimilars: Health Canada's guidance, approvals and reviews of biosimilars to date, the effect of CETA amendments to biologics, pending patent litigation...
Smart & Biggar/Fetherstonhaugh
On February 2, the FCA allowed Apotex's appeal of a $61 million award disgorging Apotex's profits for its generic perindopril (COVERSYL).
Devry Smith Frank LLP
The Cannabis Act, once in force, prescribes a number of limitations regarding the personal cultivation and consumption of marijuana in Canada.
Osler, Hoskin & Harcourt LLP
Aurora issued a press release announcing that it had submitted a proposal to the board of directors of CanniMed to acquire all of the issued and outstanding common shares of CanniMed.
Dentons
The last year has been filled with sensational headlines relating to the spectacular growth and rise to prominence of Licensed Producers (as defined below) in response to the federal government's plan ...
Smart & Biggar/Fetherstonhaugh
Health Canada publishes final guidance documents on quality requirements for regulatory filings
Cassels Brock
Days after recreational cannabis legalization in California, Attorney General Jeff Sessions announced the rescission of the "Cole memo," moving to change the country's policy ...
Smart & Biggar/Fetherstonhaugh
The Health Sector Payment Transparency Act, 2017 will come into force on a day to be named by proclamation of the Lieutenant Governor.
Blake, Cassels & Graydon LLP
On January 4, 2018, U.S. Attorney General Jeff Sessions issued a memorandum to U.S. attorneys, which rescinded all previous nationwide guidance specific to cannabis enforcement, ...
Latest Video
Most Popular Recent Articles
Borden Ladner Gervais LLP
Our annual thought leadership report is now available to download.
Devry Smith Frank LLP
Bill C-45 (An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts), also known as Canada's proposed Cannabis Act ...
Norton Rose Fulbright Canada LLP
As the government prepares for legalization of recreational marijuana this summer, Canada's cannabis producers and distributors are bracing themselves for a period of consolidation leading up to and following legalization.
Howie, Sacks & Henry
The blood coursing through our veins distributes the oxygen, nutrients and energy our organs need to function and stay healthy.
Norton Rose Fulbright Canada LLP
Last week, we covered EY's recently released report (the Report) surveying the bourgeoning cannabis sector in Canada.
Osler, Hoskin & Harcourt LLP
Aurora issued a press release announcing that it had submitted a proposal to the board of directors of CanniMed to acquire all of the issued and outstanding common shares of CanniMed.
Gowling WLG
The Canadian government recently published its proposed Regulations Amending the Patented Medicines Regulations (the "Regulations") for coming into force January 1, 2019.
Devry Smith Frank LLP
Over the last half of 2017 there was a flood of information on what was going to take effect in 2018 and how we are to prepare for it all, taking the form of articles and news segments ...
Langlois lawyers, LLP
In prevision of the legalization of cannabis, which will become effective on July 1, 2018, provinces had to provide the legal frame to be respected by individuals and companies.
Pallett Valo LLP
The legal use and regulation of cannabis (marijuana) for recreational purposes in Canada is fast approaching. Surveys have demonstrated that about two-thirds of Canadians support the legalization of cannabis.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with